Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Should CreXus Shareholders Buy Annaly?

Make no mistake about it: Annaly Capital  (NYSE: NLY  ) is concerned.

Consider the statement from CEO Wellington Denahan-Norris in the company's quarterly earnings release:

The active involvement of policymakers in the mortgage market, particularly the Federal Reserve's latest, open-ended, large scale asset purchase program, has introduced unique challenges for all investors. These policy decisions will have consequences in a wide range of markets, not just Agency mortgage-backed securities. We continue to pursue a conservative stance in these conditions, as we assess relative value opportunities across asset classes, on both sides of our balance sheet and throughout our business.

Now, if you can picture Denahan-Norris saying the "introduced unique challenges" bit in a seething tone through clenched teeth, then you're probably on the right track.

Indeed, the Fed's policies have not been kind to mortgage REITs. Annaly's interest rate spread fell to 1.24% by the end of the third quarter, which was down from 1.96% the year before. This isn't particular to Annaly -- American Capital Agency's (NASDAQ: AGNC  ) Q3 average spread was 1.42%, versus 2.14% in the year-prior quarter.

There's no real hope on the horizon, either, in terms of a more comfortable rate environment. The Fed is aggressively pursuing its quantitative easing ends, and unless there's some drastic, unexpected turnaround in employment or inflation indicators, it seems very likely that this push will continue for the foreseeable future.

And this has put CreXus  (UNKNOWN: CXS.DL.DL  ) shareholders in a tough position. 

Let's make a deal
With Annaly's freshly announced proposal to buy CreXus outright for cash, CreXus shareholders could soon find themselves with a pile of cash that needs to be reinvested. Perhaps the most obvious first place to look -- as the title of this article implies -- is Annaly. 

For those investors with a "see a big dividend, buy a big dividend" strategy -- a strategy which, by the way, is not recommended -- the switch from CreXus to Annaly is a no-brainer since Annaly actually sports a heftier yield. Management is another easy consideration since CreXus was already managed by FIDAC, Annaly's wholly owned investment advisor. In fact, if you click over to CreXus' "management perspective," you get a commentary with Annaly's logo plastered at the top. 

But strategically, and from a portfolio perspective, the move from CreXus to Annaly is considerable. Even if it does complete the acquisition of CreXus, Annaly's bottom line will be hugely weighted toward its current assets since it finished Q3 with $142 billion in assets to CreXus' less-than-$1 billion. And the nature of the portfolios are extremely different, with Annaly's focused on agency-backed securities ($130 billion worth) while CreXus' is focused on direct mortgage lending and even some direct real-estate investments.

As far as risk profile, there are pros and cons to each. Investors moving from CreXus to Annaly are going from a basically unlevered balance sheet to one that's notably levered through largely short-term repo borrowing. Jumping in on Annaly also exposes CreXus investors to the rate risk that Annaly is trying to address through this deal. Of course, on the flip side, CreXus' portfolio is heavily weighted toward mezzanine commercial mortgage loans -- not exactly a port-in-the-storm asset flavor.

Considering all of this, I can't blame Annaly for wanting to swallow CreXus -- in the current environment I see it as a much more attractive portfolio. Even over the longer term, if I had to pick one, there's a lot to like about CreXus' approach of filling the funding gaps left where banks are still hesitant on the lending front. So should current CreXus investors make the switch if the deal goes through? They shouldn't dismiss it out of hand, but it's well worth exploring other available options.

A closer look at Annaly
Thinking about taking the plunge on Annaly? You'd better make sure you fully understand the business and the risks that the company is facing. In this premium research report on Annaly, our analyst runs through the absolute must-know topics, as well as the future opportunities and pitfalls of its strategy. Click here now to claim your copy.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2110403, ~/Articles/ArticleHandler.aspx, 10/26/2016 11:07:08 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,199.33 30.06 0.17%
S&P 500 2,139.43 -3.73 -0.17%
NASD 5,250.27 -33.13 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 4:00 PM
AGNC $20.26 Up +0.08 +0.40%
American Capital A… CAPS Rating: ***
CXS.DL.DL $0.00 Down +0.00 +0.00%
CreXus Investment CAPS Rating: ***
NLY $10.41 Up +0.04 +0.39%
Annaly Capital Man… CAPS Rating: ****